Misaki Wayengera
#173,420
Most Influential Person Now
Researcher
Misaki Wayengera's AcademicInfluence.com Rankings
Misaki Wayengeraengineering Degrees
Engineering
#9322
World Rank
#11064
Historical Rank
Cybernetics
#208
World Rank
#220
Historical Rank
Biomedical Engineering
#971
World Rank
#990
Historical Rank
Applied Physics
#3709
World Rank
#3846
Historical Rank
Download Badge
Engineering
Misaki Wayengera's Degrees
- PhD Biomedical Engineering University of California, Berkeley
- Masters Biomedical Engineering University of California, Berkeley
- Bachelors Biomedical Engineering University of California, Berkeley
Why Is Misaki Wayengera Influential?
(Suggest an Edit or Addition)According to Wikipedia, Misaki Wayengera is a Ugandan physician, academician, and a medical researcher. He serves as a lecturer for Pathology, Immunology and Molecular Biology at Makerere University College of Health Sciences. He is the chairperson of Uganda's Scientific Advisory Committee on COVID-19 for the Ministry of Health and the National Task Force.
Misaki Wayengera's Published Works
Published Works
- Enabling the genomic revolution in Africa (2014) (327)
- Whole-Exome Sequencing Reveals Uncaptured Variation and Distinct Ancestry in the Southern African Population of Botswana. (2018) (32)
- The collaborative African genomics network training program: a trainee perspective on training the next generation of African scientists (2017) (24)
- Proviral HIV-genome-wide and pol-gene specific Zinc Finger Nucleases: Usability for targeted HIV gene therapy (2011) (20)
- Searching for New Clues about the Molecular Cause of Endomyocardial Fibrosis by Way of In Silico Proteomics and Analytical Chemistry (2009) (15)
- Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursors (2011) (14)
- The Collaborative African Genomics Network (CAfGEN): Applying Genomic technologies to probe host factors important to the progression of HIV and HIV-tuberculosis infection in sub-Saharan Africa (2018) (9)
- Zinc finger arrays binding human papillomavirus types 16 and 18 genomic DNA: precursors of gene-therapeutics for in-situ reversal of associated cervical neoplasia (2012) (9)
- Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease (2018) (7)
- Identification of restriction endonuclease with potential ability to cleave the HSV-2 genome: Inherent potential for biosynthetic versus live recombinant microbicides (2008) (7)
- Harnessing Pharmacogenomics to Tackle Resistance to the “Nucleoside Reverse Trancripatse Inhibitor” Backbone of Highly Active Antiretroviral Therapy in Resource Limited Settings (2008) (6)
- Whole-genome sequencing of SARS-CoV-2 in Uganda: implementation of the low-cost ARTIC protocol in resource-limited settings (2021) (6)
- Immuno-diagnosis of Mycobacterium tuberculosis in sputum, and reduction of timelines for its positive cultures to within 3 h by pathogen-specific thymidylate kinase expression assays (2017) (6)
- Targeting persistent HIV infection: Where and how, if possible? (2011) (5)
- Selecting a Laboratory Information Management System for Biorepositories in Low- and Middle-Income Countries: The H3Africa Experience and Lessons Learned (2017) (5)
- On the general theory of the origins of retroviruses (2010) (4)
- Sero-diagnosis of Active Mycobacterium tuberculosis Disease among HIV Co-infected Persons using Thymidylate Kinase based Antigen and Antibody Capture Enzyme Immuno-Assays (2017) (4)
- Genomic-Regulation of Active Retroviral Elements as a Model for HIV Cure (2015) (4)
- Theoretical basis for reducing time-lines to the determination of positive Mycobacterium tuberculosis cultures using thymidylate kinase (TMK) assays (2009) (4)
- Zinc finger nucleases for targeted mutagenesis and repair of the sickle-cell disease mutation: An in-silico study (2012) (3)
- In silico evidence for the species-specific conservation of mosquito retroposons: implications as a molecular biomarker (2009) (3)
- The Collaborative African Genomics Network (CAfGEN): Applying Genomic technologies to probe host factors important to the progression of HIV and HIV-tuberculosis infection in sub-Saharan Africa. (2018) (3)
- Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial (2021) (2)
- Ebola Virus Disease and Current Therapeutic Strategies: A Review. (2021) (2)
- Unmapped exome reads implicate a role for Anelloviridae in childhood HIV-1 long-term non-progression (2021) (2)
- Uganda homosexuality report in context. (2014) (2)
- Exome Sequencing Reveals a Putative Role for HLA-C*03:02 in Control of HIV-1 in African Pediatric Populations (2021) (2)
- In Vitro Transduction and Target-Mutagenesis Efficiency of HIV-1 pol Gene Targeting ZFN and CRISPR/Cas9 Delivered by Various Plasmids and/or Vectors: Toward an HIV Cure. (2017) (2)
- Targeting wild-type Erythrocyte receptors for Plasmodium falciparum and vivax Merozoites by Zinc Finger Nucleases In- silico: Towards a Genetic Vaccine against Malaria (2012) (2)
- Pre-Integration gene slicing as an alternate or complimentary gene therapy modem to RNA interference (2008) (2)
- Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection (2018) (1)
- Zinc finger arrays binding human papillomavirus types 16 and 18 genomic DNA: precursors of gene-therapeutics for in-situ reversal of associated cervical neoplasia (2012) (1)
- Slow progression of paediatric HIV disease: Selective adaptation or a chance phenomenon? (2007) (1)
- Multiple protein-domain conservation architecture as a non-deterministic confounder of linear B cell epitopes (2015) (0)
- Safety and Feasibility of Autologous Adipose-derived Stromal Vascular Fraction in the Treatment of Keloids: a Phase One Randomised Controlled Pilot Trial (2021) (0)
- Unmapped exome reads implicate a role for Anelloviridae in childhood HIV-1 long-term non-progression (2021) (0)
- Predicted role of small non-coding Ribonucleic acids (ncRNAs) and Ribonucleoproteins (RNPs) in Influenza genetic shifts and drifts (2008) (0)
- Cloning, Expression and Purification of Recombinant Forms of Full Length and Extracellular Domain EBOV Glycoprotein within Mammalian Cell-Lines (2019) (0)
- Halting Progression to Acute Respiratory Distress Syndrome in COVID19 using Angiotensin Converting Enzyme II Receptor Antagonists (2021) (0)
- Smart, nano-engineered drug (NRTI)-immune conjugates for targeting HIV within reservoirs (2011) (0)
- Mycobacterium Tuberculosis Thymidylate Kinase is A Potential 2 Diagnostic Biomarker for Pulmonary Tuberculosis (2020) (0)
- Immuno-diagnosis of Mycobacterium tuberculosis in sputum, and reduction of timelines for its positive cultures to within 3 h by pathogen-specific thymidylate kinase expression assays (2017) (0)
- The contribution of medical biotechnology in the sustainability of human society (2010) (0)
- The Need for Combination Antiviral Therapy for Effective Treatment of COVID-19 (2021) (0)
- Open African Reference Pathology Data Center (2014) (0)
- Strengthening the maternal and child health responses to Ebola outbreaks in Uganda (2023) (0)
- Is there need for a desensitization program for patients who shared the same ward with a late colleague? (2006) (0)
- Safety and Efficacy of Hydroxychloroquine for Treatment of Non-Severe COVID-19 in Adults in Uganda: A Randomized Open Label Phase II Clinical Trial (2021) (0)
- Variations in Trim5α and Cyclophilin A genes among HIV-1 elite controllers and non controllers in Uganda: a laboratory-based cross-sectional study (2019) (0)
- Adipose-derived stromal vascular fraction (SVF) in scar treatment: a systematic review protocol. (2022) (0)
This paper list is powered by the following services:
Other Resources About Misaki Wayengera
What Schools Are Affiliated With Misaki Wayengera?
Misaki Wayengera is affiliated with the following schools: